BioTrove and Sitris Expand HTS Relationship
News Nov 10, 2005
BioTrove has announced the expansion of its relationship with Sirtris Pharmaceuticals. As part of the ongoing relationship, BioTrove will use its proprietary RapidFire™ Lead Discovery service for assay development and high throughput screening on an undisclosed number of Sirtris targets.
RapidFire™ Lead Discovery uses high throughput mass spectrometry to perform label-free assays using native biological substrates enabling the screening of intractable targets.
“The expansion of our relationship with Sirtris provides further validation of the value of RapidFire™ Lead Discovery,” said Alan Carter, vice president of business development and field operations.
“Our expanding customer base continues to find new leads and information on valuable targets when compared to classical HTS methods.”
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019